New shot delivery method tested in healthy men
NCT ID NCT06951828
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested two different devices for giving a single dose of the biologic drug CT-P43: an auto-injector and a pre-filled syringe. It involved 162 healthy men aged 19 to 55. The goal was to see if the two methods deliver the drug similarly into the body and to check for any safety issues.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CT-P43 (a biologic drug given as a shot under the skin)
- What this could lead to
- If successful, this could show that the auto-injector works as well as the pre-filled syringe, making it easier for patients to give themselves the medicine.
- What could go wrong
- This is an early-phase trial in healthy men, not patients. It only checks how the body handles the drug and basic safety, not whether it treats any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY MALE SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Korea University Guro Hospital
Seoul, Guro-gu, 08308, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.